Total Payments
$400,249
2024 Payments
$61,998
Companies
28
Transactions
440
Medicare Patients
446
Medicare Billing
$52,053
Payment Breakdown by Category
Other$284,759 (71.1%)
Travel$58,751 (14.7%)
Consulting$45,119 (11.3%)
Food & Beverage$11,621 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $218,844 | 118 | 54.7% |
| Honoraria | $60,729 | 15 | 15.2% |
| Travel and Lodging | $58,751 | 80 | 14.7% |
| Consulting Fee | $45,119 | 32 | 11.3% |
| Food and Beverage | $11,621 | 194 | 2.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,186 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $170,106 | 196 | $0 (2021) |
| H. Lundbeck A S | $68,710 | 23 | $0 (2024) |
| Lilly USA, LLC | $26,810 | 35 | $0 (2022) |
| Lundbeck LLC | $19,024 | 16 | $0 (2024) |
| ABBVIE INC. | $17,254 | 18 | $0 (2024) |
| Allergan, Inc. | $16,816 | 23 | $0 (2020) |
| Promius Pharma LLC | $13,658 | 16 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $13,584 | 16 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $10,533 | 10 | $0 (2019) |
| ASSERTIO THERAPEUTICS, Inc. | $9,140 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,998 | 40 | H. Lundbeck A S ($46,866) |
| 2023 | $25,362 | 23 | H. Lundbeck A S ($19,130) |
| 2022 | $8,824 | 14 | IMPEL PHARMACEUTICALS INC. ($2,639) |
| 2021 | $13,076 | 16 | BioDelivery Sciences International, Inc. ($3,000) |
| 2020 | $54,416 | 43 | Allergan, Inc. ($16,136) |
| 2019 | $108,521 | 136 | Amgen Inc. ($71,403) |
| 2018 | $95,135 | 118 | Amgen Inc. ($72,871) |
| 2017 | $32,918 | 50 | Avanir Pharmaceuticals, Inc. ($7,508) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $95.75 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $73.44 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | H. Lundbeck A S | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $11,240.00 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | H. Lundbeck A S | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $5,940.00 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | H. Lundbeck A S | VYEPTI (Biological) | Travel and Lodging | Cash or cash equivalent | $260.00 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | H. Lundbeck A S | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $112.00 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 08/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $8.59 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | H. Lundbeck A S | VYEPTI (Biological) | Travel and Lodging | In-kind items and services | $7,009.38 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | H. Lundbeck A S | VYEPTI (Biological) | Honoraria | Cash or cash equivalent | $3,200.00 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | H. Lundbeck A S | VYEPTI (Biological) | Travel and Lodging | In-kind items and services | $1,103.16 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | H. Lundbeck A S | VYEPTI (Biological) | Food and Beverage | In-kind items and services | $395.09 | General |
| Category: NEUROLOGY | ||||||
| 06/25/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| 06/14/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: NEUROLOGY | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $121.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: PAIN | ||||||
| 06/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 05/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 05/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/24/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $9.42 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 115 | $37,460 | $9,886 |
| 2022 | 3 | 102 | 128 | $46,280 | $12,482 |
| 2021 | 4 | 136 | 160 | $61,990 | $16,856 |
| 2020 | 5 | 124 | 151 | $74,890 | $12,829 |
Total Patients
446
Total Services
554
Medicare Billing
$52,053
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 48 | $18,000 | $4,535 | 25.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 25 | $8,875 | $2,515 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 25 | $6,250 | $1,672 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $4,335 | $1,165 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 79 | $29,625 | $8,370 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 36 | $9,180 | $2,595 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $7,475 | $1,517 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 82 | $30,750 | $8,615 | 28.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 26 | $12,220 | $3,012 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $10,350 | $2,632 | 25.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 34 | $8,670 | $2,597 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 70 | $26,250 | $6,061 | 23.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 30 | 30 | $17,250 | $3,961 | 23.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 11 | 11 | $2,410 | $1,046 | 43.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 17 | $4,335 | $902.48 | 20.8% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 11 | 23 | $24,645 | $858.98 | 3.5% |
About Dr. P. Christopher Gottschalk, M.D
Dr. P. Christopher Gottschalk, M.D is a Neurology healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831131176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. P. Christopher Gottschalk, M.D has received a total of $400,249 in payments from pharmaceutical and medical device companies, with $61,998 received in 2024. These payments were reported across 440 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($218,844).
As a Medicare-enrolled provider, Gottschalk has provided services to 446 Medicare beneficiaries, totaling 554 services with total Medicare billing of $52,053. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fairfield, CT
- Active Since 06/12/2006
- Last Updated 07/07/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831131176
Products in Payments
- Aimovig (Biological) $140,009
- VYEPTI (Biological) $83,504
- UBRELVY (Drug) $19,083
- EMGALITY (Drug) $17,184
- ONZETRA Xsail (Drug) $13,584
- Cambia (Drug) $11,616
- ZEMBRACE SYMTOUCH (Drug) $9,606
- Zembrace (Drug) $6,715
- TREXIMET (Drug) $6,311
- AIMOVIG (Biological) $4,689
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $3,441
- ELYXYB - CELECOXIB (Drug) $3,000
- Trudhesa (Drug) $2,768
- ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION (Drug) $2,740
- ONZETRA XSAIL (Drug) $2,250
- AJOVY (Biological) $1,515
- TOSYMRA (Drug) $1,380
- BOTOX (Biological) $710.99
- NURTEC ODT (Drug) $353.10
- TEV-48125 (Biological) $188.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfield
Peter Mcallister, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
Jeffrey Gross, M.d, M.D
Neurology — Payments: $191,862
Neurology $191,862
Dr. Nicholas Blondin, M.d, M.D
Neurology — Payments: $144,704
Neurology $144,704
Srinath Kadimi, M.d, M.D
Neurology — Payments: $44,527
Neurology $44,527
Dario Zagar, M.d, M.D
Neurology — Payments: $19,926
Neurology $19,926
Mrs. Ruby Ali, M.d, M.D
Neurology — Payments: $18,050
Neurology $18,050